Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p4)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

91-140 of about 500 reports
Emerging NIPT Market in Asia Pacific

Emerging NIPT Market in Asia Pacific

  • $ 1 200
  • Industry report
  • November 2013
  • by RNCOS

Non-Invasive Prenatal Testing (NIPT) has catapulted the growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, Japan, China, Asia, World, Oceania, India, United States
Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

Global Age-Related Macular Degeneration (AMD) Market: Trends and Opportunities (2013-2018)

  • $ 800
  • Industry report
  • November 2013
  • by Daedal Research

Scope of the report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration ...

  • Industries : Pathology
  • Countries : World, Australia
Meningococcal Meningitis - Pipeline Review, H2 2013

Meningococcal Meningitis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Meningococcal Meningitis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Meningococcal Meningitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World, Australia
Physiotherapy Services Market in Australia

Physiotherapy Services Market in Australia

  • $ 890
  • Industry report
  • October 2013
  • by Ibisworld

IBISWORLD This is the replacement for IBISWorld's October Physiotherapy Services in Australia About this Market This market research report from IBISWorld provides a in-depth overview of the Physiotherapy ...

  • Industries : Therapy
  • Countries : Australia
Therapy Class Overview : Hepatitis C Virus Infection

Therapy Class Overview : Hepatitis C Virus Infection

  • $ 1 000
  • Industry report
  • October 2013
  • by MP Advisors

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future. This year the first IFN-free ...

  • Industries : Pathology
  • Countries : Asia, World, Australia, Saudi Arabia, Vietnam, Taiwan, Syrian Arab Republic, Pakistan, India, China, Egypt
Global Testosterone Replacement Therapy (TRT) Industry

Global Testosterone Replacement Therapy (TRT) Industry

  • $ 4 950
  • Industry report
  • October 2013
  • by Global Industry Analysts

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the following Product Segments: Topicals, Patches, ...

  • Industries : Drug and Medication
  • Countries : World, United States, Canada, Europe, Germany, Italy, France, United Kingdom, North America, Australia
Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

  • $ 10 995
  • Industry report
  • October 2013
  • by iData Research, Inc.

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, ...

  • Industries : Pathology
  • Countries : World, Europe, South America, Australia, Argentina, North America, Brazil, Mexico, Oceania, Canada, Switzerland, Netherlands, Sweden, Spain, Portugal, Italy, Germany, Finland, Denmark, Belgium, Austria
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies

  • $ 3 500
  • Industry report
  • September 2013
  • by GBI Research

Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies Summary GBI Research, the leading business ...

  • Industries : Pathology
  • Countries : World, Australia, China, Japan, India, Asia
PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • September 2013
  • by Global Data

PharmaPoint: Meningococcal Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - Australia Drug ...

  • Industries : Drug and Medication
  • Countries : Australia
Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menveo (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Australia, World, Brazil, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, China, Oceania, South America
Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Nimenrix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Europe, Australia, United States, United Kingdom, China
Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menitorix (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Spain, World, Brazil, Italy, France, Germany, Japan, United Kingdom, Australia, Europe, United States, China
Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Meningitec (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, Oceania
Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Brazil, World, Australia, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, China, South America, Oceania
NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

NeisVac-C (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Brazil, Spain, Italy, France, Germany, Japan, United Kingdom, Europe, United States, China, Oceania
Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Bexsero (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, Australia, Europe, United States, United Kingdom, China
New Zealand Business Projection Industry Update Quarter 4 2011

New Zealand Business Projection Industry Update Quarter 4 2011

  • $ 1 208
  • Industry report
  • September 2013
  • by Business Monitor International

Core Views We believe the damage caused by the second Christchurch earthquake, ongoing property correction and debt deleveraging will weigh on growth. In view of these factors, we are projecting real ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

Phosphagenics Limited : Ingredients - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • September 2013
  • by Canadean Ltd

Synopsis Canadean's "Phosphagenics Limited : Ingredients - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a ...

  • Industries : Drug and Medication
  • Countries : Australia
Commonwealth Scientific and Industrial Research Organisation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Commonwealth Scientific and Industrial Research Organisation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2013
  • by Global Data

Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is Australia's national science agency. The company's research areas include climate adaptation, biosecurity, energy transformation, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Phosphagenics Limited (POH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Phosphagenics Limited (POH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2013
  • by Global Data

Summary Phosphagenics Limited (Phosphagenics) is a pharmaceutical company. The company discovers, develops and commercializes pharmaceutical, nutraceutical and cosmeceutical products. Its products unde ...

  • Industries : Pharmaceutical
  • Countries : Australia
Dermatitis - Pipeline Review, H2 2013

Dermatitis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • September 2013
  • by Global Markets Direct

Dermatitis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Dermatitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : World, Australia, United States
Polio - Pipeline Review, H2 2013

Polio - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • September 2013
  • by Global Markets Direct

Polio - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Polio - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Pharmacies Market in Australia

Pharmacies Market in Australia

  • $ 890
  • Industry report
  • September 2013
  • by Ibisworld

Healthy and wealthy: The market maintains mature growth as competition intensifies Pharmacies in Australia This market covers all pharmacies involved in the sale of prescription drugs and patent medicines. ...

  • Industries : Pharmacies and Drug Stores
  • Countries : Australia
LEO Pharma AS - Strategic SWOT Analysis Review

LEO Pharma AS - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • September 2013
  • by Global Data

LEO Pharma AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Ireland, France, Denmark
New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2013
  • by Business Monitor International

BMI View: New Zealand’s pharmaceutical industry has a classic low risk, low reward profile. Multinational drugmakers are attracted to the country’s non-communicable disease burden, direct-toconsume ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Australia Business Projection Industry Update Quarter 4 2011

Australia Business Projection Industry Update Quarter 4 2011

  • $ 1 208
  • Industry report
  • September 2013
  • by Business Monitor International

Core Views We believe the negative impact of the recent natural disasters in Queensland, business debt deleveraging and weakening home prices will weigh on growth, although strong export performance owing ...

  • Industries : Drug and Medication
  • Countries : Australia
Chemical & Pharmaceutical Plant Construction in Australia to 2017: Market Databook

Chemical & Pharmaceutical Plant Construction in Australia to 2017: Market Databook

  • $ 500
  • Industry report
  • August 2013
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Australia to 2017: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Australia
Premature Ejaculation - Pipeline Review, H2 2013

Premature Ejaculation - Pipeline Review, H2 2013

  • $ 2 000
  • Industry report
  • August 2013
  • by Global Markets Direct

Premature Ejaculation - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Premature Ejaculation - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World, Australia
Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Australia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2013
  • by Business Monitor International

BMI View: Australian prospects for multinational drugmakers are mixed. In the first quarter of the year it was announced that eight medicines would not be included in the country's Pharmaceutical Benefits ...

  • Industries : Drug and Medication
  • Countries : Australia
OTC Pharmaceuticals Market Overview in Australia

OTC Pharmaceuticals Market Overview in Australia

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

It includes data on industry size and key market segments, plus textual and graphical analysis of the major trends and drivers and key competitors, main industry players and demographic information. What's ...

  • Industries : Over-the-counter Drug
  • Countries : Australia

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.